Grant: Banting Postdoctoral Fellowship Program
Direct Payment
$140,000.00
The contribution of germline variants to somatic EGFR mutation risk in lung adenocarcinoma in the Latin American populations.
EF 2018-19
Résumé
Ancestry is a risk factor and predictor of poor outcomes for cancers. In Canada, there are more than 1.3 million people identified as being of Native American heritage. This proposal will answer a critical question: why people with Native American ancestry, particularly non-smokers, tend to have higher risk of lung cancer with genetic change (mutation) in a gene called EGFR, than other populations? My hypothesis is that inherited genetic variations play a role. In other words, the more Native American gene elements inherited, the higher risk of getting EGFR mutations that drive the development of lung cancer, regardless if they are smokers or not.
To test my hypothesis, I will focus on an admixed population, the Latin American population, where people share different ancestors but similar environmental exposures. Latin Americans consist of a three-way admixture of ancestral populations: European, African and Native American. Moreover, East Asian and indigenous Amerindian populations share elements of their genes. Notably, East Asian lung cancer patients also have a strikingly high frequency of EGFR mutations.
The approach I will use is to study patients' genome - genome inherited from the ancestors - and tumor genome - genome with mutations causing cancer - in a systematic manner. I will use advanced sequencing technologies to decipher the genetic code in the Latin American lung cancer patients who have EGFR mutations in their tumors. My mentor and I will bring together international researchers to achieve the common goal.
The completion of the proposed work will discover the molecular mechanism contributing to the increased EGFR mutation risk. The findings will be highly transformative in lung cancer prevention, screening and early detection for non-smokers in Canada. My work will open a new field of studying host and tumor genome together, and inspire future cancer studies for the indigenous populations.
Programme
Banting Postdoctoral Fellowship Program
Bénéficiaire
Emplacement
Massachusetts, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
392399
Name
Carrot-Zhang Jian
Region
Massachusetts
Country
United States of America
Orgtype
Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Banting Postdoctoral Fellowships Program
Projecttitle
The contribution of germline variants to somatic EGFR mutation risk in lung adenocarcinoma in the Latin American populations.
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$140,000
Cihrequipment2
$0
Programname2
Banting Postdoctoral Fellowship Program
Keyworddelim
Ancestral Contribution; Egfr Mutation Risk; Germline Variant Contribution; Latin American Patients; Lung Adenocarcinoma; Whole-Genome Sequencing
Abstract
Ancestry is a risk factor and predictor of poor outcomes for cancers. In Canada, there are more than 1.3 million people identified as being of Native American heritage. This proposal will answer a critical question: why people with Native American ancestry, particularly non-smokers, tend to have higher risk of lung cancer with genetic change (mutation) in a gene called EGFR, than other populations? My hypothesis is that inherited genetic variations play a role. In other words, the more Native American gene elements inherited, the higher risk of getting EGFR mutations that drive the development of lung cancer, regardless if they are smokers or not.
To test my hypothesis, I will focus on an admixed population, the Latin American population, where people share different ancestors but similar environmental exposures. Latin Americans consist of a three-way admixture of ancestral populations: European, African and Native American. Moreover, East Asian and indigenous Amerindian populations share elements of their genes. Notably, East Asian lung cancer patients also have a strikingly high frequency of EGFR mutations.
The approach I will use is to study patients' genome - genome inherited from the ancestors - and tumor genome - genome with mutations causing cancer - in a systematic manner. I will use advanced sequencing technologies to decipher the genetic code in the Latin American lung cancer patients who have EGFR mutations in their tumors. My mentor and I will bring together international researchers to achieve the common goal.
The completion of the proposed work will discover the molecular mechanism contributing to the increased EGFR mutation risk. The findings will be highly transformative in lung cancer prevention, screening and early detection for non-smokers in Canada. My work will open a new field of studying host and tumor genome together, and inspire future cancer studies for the indigenous populations.
Competitiondate
201809
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Carrot-Zhang, Jian
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $140,000~ $0~